US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist
  • 30.760
  • +0.125+0.41%
Trading Nov 21 15:15 ET
2.15BMarket Cap-8137P/E (TTM)

Akero Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
29.30%717.25M
18.88%760.19M
163.29%903.67M
56.50%550.01M
56.50%550.01M
48.32%554.73M
253.82%639.44M
107.54%343.22M
86.68%351.45M
86.68%351.45M
-Cash and cash equivalents
17.26%316.07M
-30.12%310.36M
141.91%623.85M
-6.23%234.21M
-6.23%234.21M
-27.93%269.55M
149.91%444.16M
71.36%257.88M
65.98%249.77M
65.98%249.77M
-Short-term investments
40.67%401.18M
130.35%449.84M
227.89%279.81M
210.60%315.8M
210.60%315.8M
--285.19M
6,413.94%195.29M
473.24%85.34M
169.16%101.68M
169.16%101.68M
Other current assets
39.51%29.64M
320.75%15.82M
78.46%7.62M
167.24%9.95M
167.24%9.95M
438.85%21.25M
9.85%3.76M
66.81%4.27M
-30.05%3.72M
-30.05%3.72M
Total current assets
29.67%746.89M
20.65%776.01M
162.25%911.28M
57.66%559.96M
57.66%559.96M
52.40%575.98M
249.29%643.2M
106.92%347.49M
83.47%355.17M
83.47%355.17M
Non current assets
Net PPE
-23.25%835K
-21.88%900K
-21.13%963K
-20.40%1.03M
-20.40%1.03M
-19.65%1.09M
-18.87%1.15M
-17.78%1.22M
-16.79%1.29M
-16.79%1.29M
-Gross PPE
-23.25%835K
-21.88%900K
-21.13%963K
-20.40%1.03M
-20.40%1.03M
-19.65%1.09M
-18.87%1.15M
-17.78%1.22M
-16.79%1.29M
-16.79%1.29M
Investments and advances
19.84%69.82M
353.10%88.13M
--0
--19.28M
--19.28M
--58.26M
--19.45M
----
--0
--0
Other non current assets
----
----
----
----
----
----
----
-76.92%108K
-74.10%108K
-74.10%108K
Total non current assets
19.05%70.66M
332.14%89.03M
-27.54%963K
1,353.76%20.31M
1,353.76%20.31M
3,959.64%59.35M
1,248.36%20.6M
-31.95%1.33M
-28.94%1.4M
-28.94%1.4M
Total assets
28.68%817.55M
30.32%865.04M
161.52%912.24M
62.74%580.27M
62.74%580.27M
67.45%635.33M
257.51%663.81M
105.32%348.82M
82.34%356.57M
82.34%356.57M
Liabilities
Current liabilities
Payables
120.21%25.22M
43.94%14.57M
94.68%13.78M
-11.67%7.04M
-11.67%7.04M
90.58%11.45M
47.17%10.12M
59.10%7.08M
18.82%7.97M
18.82%7.97M
-accounts payable
120.21%25.22M
43.94%14.57M
94.68%13.78M
-11.67%7.04M
-11.67%7.04M
90.58%11.45M
47.17%10.12M
59.10%7.08M
18.82%7.97M
18.82%7.97M
Current accrued expenses
18.71%13.07M
49.21%12.86M
82.72%13.61M
2.86%10.27M
2.86%10.27M
-32.69%11.01M
-51.20%8.62M
-53.41%7.45M
-43.46%9.99M
-43.46%9.99M
Current debt and capital lease obligation
-75.55%631K
27.59%629K
56.10%640K
60.62%522K
60.62%522K
751.82%2.58M
93.33%493K
93.40%410K
58.54%325K
58.54%325K
-Current debt
----
----
----
----
----
--2.08M
----
----
----
----
-Current capital lease obligation
24.95%631K
27.59%629K
56.10%640K
60.62%522K
60.62%522K
66.67%505K
93.33%493K
93.40%410K
58.54%325K
58.54%325K
Current liabilities
52.18%43.29M
44.31%31.17M
81.43%30.26M
0.24%19.13M
0.24%19.13M
12.69%28.45M
-19.08%21.6M
-24.52%16.68M
-24.06%19.08M
-24.06%19.08M
Non current liabilities
Long term debt and capital lease obligation
51.03%35.73M
38.77%35.64M
38.70%35.55M
142.78%25.78M
142.78%25.78M
123.44%23.66M
143.09%25.68M
1,942.47%25.63M
710.07%10.62M
710.07%10.62M
-Long term debt
54.26%35.12M
41.37%34.96M
41.38%34.8M
161.65%24.96M
161.65%24.96M
141.01%22.77M
164.02%24.73M
--24.62M
--9.54M
--9.54M
-Long term capital lease obligation
-31.87%605K
-28.83%679K
-26.25%750K
-24.10%819K
-24.10%819K
-22.11%888K
-20.43%954K
-18.96%1.02M
-17.70%1.08M
-17.70%1.08M
Derivative product liabilities
--203K
----
----
----
----
----
----
----
----
----
Other non current liabilities
----
92.94%164K
9.88%178K
-82.30%54K
-82.30%54K
32.86%93K
107.32%85K
--162K
--305K
--305K
Total non current liabilities
51.29%35.93M
38.95%35.8M
38.52%35.73M
136.49%25.84M
136.49%25.84M
122.85%23.75M
142.95%25.77M
1,955.38%25.8M
733.33%10.93M
733.33%10.93M
Total liabilities
51.78%79.22M
41.39%66.98M
55.37%65.99M
49.84%44.97M
49.84%44.97M
45.39%52.2M
26.98%47.37M
81.88%42.47M
13.50%30.01M
13.50%30.01M
Shareholders'equity
Share capital
16.67%7K
16.67%7K
40.00%7K
20.00%6K
20.00%6K
20.00%6K
50.00%6K
25.00%5K
25.00%5K
25.00%5K
-common stock
16.67%7K
16.67%7K
40.00%7K
20.00%6K
20.00%6K
20.00%6K
50.00%6K
25.00%5K
25.00%5K
25.00%5K
Retained earnings
-45.72%-756.13M
-42.60%-683.43M
-40.00%-627.44M
-35.93%-574.1M
-35.93%-574.1M
-29.96%-518.91M
-31.76%-479.25M
-33.25%-448.17M
-36.10%-422.34M
-36.10%-422.34M
Paid-in capital
35.35%1.49B
35.20%1.48B
95.33%1.47B
48.11%1.11B
48.11%1.11B
48.43%1.1B
114.00%1.1B
56.24%754.49M
56.20%748.86M
56.20%748.86M
Gains losses not affecting retained earnings
515.61%2.1M
-3.98%-261K
-476.19%-79K
629.73%270K
629.73%270K
---506K
-8,266.67%-251K
170.00%21K
237.04%37K
237.04%37K
Total stockholders'equity
26.61%738.33M
29.46%798.07M
176.24%846.25M
63.92%535.31M
63.92%535.31M
69.76%583.14M
315.47%616.44M
109.06%306.35M
93.11%326.56M
93.11%326.56M
Total equity
26.61%738.33M
29.46%798.07M
176.24%846.25M
63.92%535.31M
63.92%535.31M
69.76%583.14M
315.47%616.44M
109.06%306.35M
93.11%326.56M
93.11%326.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 29.30%717.25M18.88%760.19M163.29%903.67M56.50%550.01M56.50%550.01M48.32%554.73M253.82%639.44M107.54%343.22M86.68%351.45M86.68%351.45M
-Cash and cash equivalents 17.26%316.07M-30.12%310.36M141.91%623.85M-6.23%234.21M-6.23%234.21M-27.93%269.55M149.91%444.16M71.36%257.88M65.98%249.77M65.98%249.77M
-Short-term investments 40.67%401.18M130.35%449.84M227.89%279.81M210.60%315.8M210.60%315.8M--285.19M6,413.94%195.29M473.24%85.34M169.16%101.68M169.16%101.68M
Other current assets 39.51%29.64M320.75%15.82M78.46%7.62M167.24%9.95M167.24%9.95M438.85%21.25M9.85%3.76M66.81%4.27M-30.05%3.72M-30.05%3.72M
Total current assets 29.67%746.89M20.65%776.01M162.25%911.28M57.66%559.96M57.66%559.96M52.40%575.98M249.29%643.2M106.92%347.49M83.47%355.17M83.47%355.17M
Non current assets
Net PPE -23.25%835K-21.88%900K-21.13%963K-20.40%1.03M-20.40%1.03M-19.65%1.09M-18.87%1.15M-17.78%1.22M-16.79%1.29M-16.79%1.29M
-Gross PPE -23.25%835K-21.88%900K-21.13%963K-20.40%1.03M-20.40%1.03M-19.65%1.09M-18.87%1.15M-17.78%1.22M-16.79%1.29M-16.79%1.29M
Investments and advances 19.84%69.82M353.10%88.13M--0--19.28M--19.28M--58.26M--19.45M------0--0
Other non current assets -----------------------------76.92%108K-74.10%108K-74.10%108K
Total non current assets 19.05%70.66M332.14%89.03M-27.54%963K1,353.76%20.31M1,353.76%20.31M3,959.64%59.35M1,248.36%20.6M-31.95%1.33M-28.94%1.4M-28.94%1.4M
Total assets 28.68%817.55M30.32%865.04M161.52%912.24M62.74%580.27M62.74%580.27M67.45%635.33M257.51%663.81M105.32%348.82M82.34%356.57M82.34%356.57M
Liabilities
Current liabilities
Payables 120.21%25.22M43.94%14.57M94.68%13.78M-11.67%7.04M-11.67%7.04M90.58%11.45M47.17%10.12M59.10%7.08M18.82%7.97M18.82%7.97M
-accounts payable 120.21%25.22M43.94%14.57M94.68%13.78M-11.67%7.04M-11.67%7.04M90.58%11.45M47.17%10.12M59.10%7.08M18.82%7.97M18.82%7.97M
Current accrued expenses 18.71%13.07M49.21%12.86M82.72%13.61M2.86%10.27M2.86%10.27M-32.69%11.01M-51.20%8.62M-53.41%7.45M-43.46%9.99M-43.46%9.99M
Current debt and capital lease obligation -75.55%631K27.59%629K56.10%640K60.62%522K60.62%522K751.82%2.58M93.33%493K93.40%410K58.54%325K58.54%325K
-Current debt ----------------------2.08M----------------
-Current capital lease obligation 24.95%631K27.59%629K56.10%640K60.62%522K60.62%522K66.67%505K93.33%493K93.40%410K58.54%325K58.54%325K
Current liabilities 52.18%43.29M44.31%31.17M81.43%30.26M0.24%19.13M0.24%19.13M12.69%28.45M-19.08%21.6M-24.52%16.68M-24.06%19.08M-24.06%19.08M
Non current liabilities
Long term debt and capital lease obligation 51.03%35.73M38.77%35.64M38.70%35.55M142.78%25.78M142.78%25.78M123.44%23.66M143.09%25.68M1,942.47%25.63M710.07%10.62M710.07%10.62M
-Long term debt 54.26%35.12M41.37%34.96M41.38%34.8M161.65%24.96M161.65%24.96M141.01%22.77M164.02%24.73M--24.62M--9.54M--9.54M
-Long term capital lease obligation -31.87%605K-28.83%679K-26.25%750K-24.10%819K-24.10%819K-22.11%888K-20.43%954K-18.96%1.02M-17.70%1.08M-17.70%1.08M
Derivative product liabilities --203K------------------------------------
Other non current liabilities ----92.94%164K9.88%178K-82.30%54K-82.30%54K32.86%93K107.32%85K--162K--305K--305K
Total non current liabilities 51.29%35.93M38.95%35.8M38.52%35.73M136.49%25.84M136.49%25.84M122.85%23.75M142.95%25.77M1,955.38%25.8M733.33%10.93M733.33%10.93M
Total liabilities 51.78%79.22M41.39%66.98M55.37%65.99M49.84%44.97M49.84%44.97M45.39%52.2M26.98%47.37M81.88%42.47M13.50%30.01M13.50%30.01M
Shareholders'equity
Share capital 16.67%7K16.67%7K40.00%7K20.00%6K20.00%6K20.00%6K50.00%6K25.00%5K25.00%5K25.00%5K
-common stock 16.67%7K16.67%7K40.00%7K20.00%6K20.00%6K20.00%6K50.00%6K25.00%5K25.00%5K25.00%5K
Retained earnings -45.72%-756.13M-42.60%-683.43M-40.00%-627.44M-35.93%-574.1M-35.93%-574.1M-29.96%-518.91M-31.76%-479.25M-33.25%-448.17M-36.10%-422.34M-36.10%-422.34M
Paid-in capital 35.35%1.49B35.20%1.48B95.33%1.47B48.11%1.11B48.11%1.11B48.43%1.1B114.00%1.1B56.24%754.49M56.20%748.86M56.20%748.86M
Gains losses not affecting retained earnings 515.61%2.1M-3.98%-261K-476.19%-79K629.73%270K629.73%270K---506K-8,266.67%-251K170.00%21K237.04%37K237.04%37K
Total stockholders'equity 26.61%738.33M29.46%798.07M176.24%846.25M63.92%535.31M63.92%535.31M69.76%583.14M315.47%616.44M109.06%306.35M93.11%326.56M93.11%326.56M
Total equity 26.61%738.33M29.46%798.07M176.24%846.25M63.92%535.31M63.92%535.31M69.76%583.14M315.47%616.44M109.06%306.35M93.11%326.56M93.11%326.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data